MedPath

Spray Skin Treats for Pediatric Burns

Recruiting
Conditions
Pediatric Burn
Registration Number
NCT06182345
Lead Sponsor
First Affiliated Hospital, Sun Yat-Sen University
Brief Summary

The treatment of burns in children remains a global challenge. At present, the clinical treatment plan is still waiting for further improvement. This study intends to retrospectively analyze the experience of treating children burn in recent years and promote sharing and application.

Detailed Description

The treatment of burns in children remains a global challenge. Children's burn wounds have many characteristics that are different from those of adults, such as easy deepening of the wound, uncooperation in dressing change, poor resistance and so on. At present, there are new dressing applications a nd surgery in clinical treatment, etc., but how to treat children to achieve better therapeutic effects still needs to be explored. This study intends to retrospectively analyze the experience of treating children burn in recent years and promote sharing and application.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • burn for any reasons
  • Children
Exclusion Criteria
  • Combined with mental illness
  • Congenital immune disease
  • Severe cardiopulmonary failure,etc

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
take ratepostoperative day 4 weeks

take rate of skin graft

Secondary Outcome Measures
NameTimeMethod
complication ratethrough study completion, an average of 6 months

after skin grafting, skin infection, necrosis, subcutaneous hematoma, etc

Trial Locations

Locations (1)

Department of Burn Surgery, The First Affiliated Hospital of Sun Yat-sen University

🇨🇳

Guangzhou, Guangdong, China

Department of Burn Surgery, The First Affiliated Hospital of Sun Yat-sen University
🇨🇳Guangzhou, Guangdong, China
Zhicheng Hu, doctor
Contact
+86 02087755766
willway128@163.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.